Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00281099 · ClinicalTrials.gov registry record · NA
Managed Ventricular Pacing ("MVP") Trial
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Terminated
- Registry status
- NA
- Development phase
- 1,031
- Enrollment target
NCT00281099 is a NA study that was terminated before completion, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 1,031 participants.
The verdict
NCT00281099, a NA study, was terminated before completion, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- TERMINATED
- Registry status
- NA
- Development phase
- 1,031 participants
- Enrollment target
Study Summary
The purpose of the study is to compare two device settings (sets of instructions) used by the ICD. The Implantable Cardiac Defibrillator ("ICD") can be set to use one wire (top or bottom of the heart) or two wires (top and bottom). The study will compare how much time either ICD wire is used by the ICD and the status of congestive heart failure.
Interventions
- DEVICE ICD (Implantable Cardioverter Defibrillator)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,031 participants |
| Start Date | 2004-10 |
| Est. Completion | 2008-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00281099
The ClinicalTrials.gov registry entry for NCT00281099 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1,031 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ICD (Implantable Cardioverter Defibrillator) is the first listed.
NCT00281099 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00281099 about?
NCT00281099 is a clinical study titled "Managed Ventricular Pacing ("MVP") Trial". The purpose of the study is to compare two device settings (sets of instructions) used by the ICD. The Implantable Cardiac Defibrillator ("ICD") can be set to use one wire (top or bottom of the heart) or two wires (top and bottom). The study will compare how much time either ICD wire is used by the ...
What is the current status of trial NCT00281099?
This trial is currently terminated. It is a NA study. The enrollment target is 1,031 participants. The study started on 2004-10. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00281099?
The interventions under investigation include: ICD (Implantable Cardioverter Defibrillator) (DEVICE).
Who is sponsoring clinical trial NCT00281099?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.